FRESENIUS KABI ONCOLOGY LTD. - Updates on Delisting Offer
Download 
|
< Back |
| 22 Oct 2013 | |
| DSP Merrill Lynch Ltd ("Manager to the Delisting Offer") on behalf of Fresenius Kabi (Singapore) Pte Ltd (Acquirer) has informed this Supplement to the Second Corrigendum to the Public Announcement ("Supplement to the Second Corrigendum") to the Public Announcement published on September 16, 2013, in respect of the proposed acquisition by Acquirer and consequent delisting of the fully paid-up equity shares of the Target Company with a face value of Re. 1 each (Shares) from the BSE Limited and the National Stock Exchange of India Limited in accordance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 and to the letter of offer issued in respect thereof inviting Bids from all Public Shareholders of the Company (Letter of Offer), is in continuation of and should be read in conjunction with the PA, the Letter of Offer, the first corrigendum to the PA and the Letter of Offer published on October 13, 2013 (First Corrigendum) and the second corrigendum to the PA and the Letter of Offer published on October 19, 2013 (Second Corrigendum).<br/><br/>The capitalised terms and abbreviations used in this Supplement to the Second Corrigendum and not defined herein have the same meaning as ascribed to them in the PA, the Letter of Offer and the Second Corrigendum, unless otherwise specified. | |
| View all announcements for FRESENIUS KABI ONCOLOGY LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback